# Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients

> **NCT01551368** · PHASE2 · TERMINATED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 12 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Nimodipine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01551368
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-04
- **Final completion:** 2017-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** small number of patients got recruited
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551368, "Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01551368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*